Each month, we screen the Europe-listed stocks under Morningstar’s coverage for newly overvalued names.
Over the past month, four stocks saw their Morningstar Ratings change to 2 stars, while none climbed into 1-star territory. Stocks rated 3 stars are fairly valued according to Morningstar analysts, while those rated 4 or 5 stars are considered undervalued.
For more information on the newly undervalued stocks, read our article.
The four new 2-star European stocks, ordered by market-cap, are:
• Assicurazioni Generali G
• Argenx ARGX
• Barclays BARC
• Be Semiconductor Industries BESI
All returns in this article are reported in the stock’s base currency and all data is sourced from Morningstar Direct.
Newly Overvalued Stocks as of Jan. 14
The Morningstar Europe Index fell 1.63% over the past month, leaving the overall European stock market moderately undervalued, hovering at a 5% discount to its fair value estimate on a cap-weighted basis.
Of the 255 Europe-listed stocks covered by Morningstar analysts:
• 49% are undervalued, 38% are fairly valued, and 13% are overvalued.
• Four are newly overvalued.
• Nine are newly undervalued.
• None moved from a 2-star rating to a 1-star rating.
• Among the newly overvalued stocks, none jumped from a 3-star rating to a 1-star rating.
• 12 are no longer overvalued.
Morningstar analysts assign every stock under their coverage a fair value estimate, which is an intrinsic measure of the stock’s worth, and an Uncertainty Rating, which captures the range of potential outcomes for that estimate. A higher Uncertainty Rating equates to a larger range of prices considered fairly valued.
These two metrics and the stock’s current price, are used to determine its Morningstar Rating.
Distribution of Star Ratings for Europe-Listed Stocks
Data is for Europe-listed stocks currently under analyst coverage.
Source: Morningstar Direct.
Metrics for this Month’s New 2-Star Stocks
Assicurazioni Generali G
• Morningstar Rating: ★★
• One-Month Return: 1.38%
Insurance firm Assicurazioni Generali has gained 7.61% over the past three months and 53.45% over the past year. The large-value stock has no economic moat. Generali is trading at a 15% premium to its fair value estimate of EUR 25.05, with an Uncertainty Rating of Medium.
Argenx ARGX
• Morningstar Rating: ★★
• One-Month Return: 12.53%
Biotechnology firm Argenx is up 31.43% over the past three months and 89.01% over the past year. The stock’s price is 33% above its fair value estimate of EUR 491, with an Uncertainty Rating of Very High. The mid-growth stock has no economic moat.
Barclays BARC
• Morningstar Rating: ★★
• One-Month Return: -2.08%
Diversified bank Barclays has gained 13.27% over the past three months and 89.48% over the past year. The large-core stock has no economic moat. Barclays is trading at a 15% premium to its fair value estimate of GBX 230, with an Uncertainty Rating of High.
Be Semiconductor Industries BESI
• Morningstar Rating: ★★
• One-Month Return: 9.60%
Semiconductor equipment and materials firm Be Semiconductor Industries is up 22.41% over the past three months and 10.11% over the past year. The stock’s price is 16% above its fair value estimate of EUR 120, with an Uncertainty Rating of High. The mid-growth stock has a narrow economic moat.
This article was generated with the help of automation and reviewed by Morningstar editors. Learn more about Morningstar’s use of automation.
The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar's editorial policies.